The United Nations has recently come under attack for its handling of both the Ebola outbreak and the war in Syria. It has prompted some to question what the role of the U.N. should be on the international stage. We look at the relevance of the U.N., 70 years after its creation.
Food scares and drug scandals have raised serious concerns over the F.D.A.’s ability to regulate effectively. A look at the resources and direction at the Food and Drug Administration, and why some are hoping for significant changes under the next administration.
- William Hubbard former associate commissioner for the Food and Drug Administration; spokesperson for the Alliance for a Stronger FDA
- Rep. Rosa DeLauro U.S. Congresswoman, representing Connecticut's 3rd district; chairwoman of the Agriculture-FDA Appropriations Subcommittee
- Alan Goldhammer, PhD associate vice president for regulatory affairs at the Pharmaceutical Research and Manufacturers of America (PhRMA)
- Dr. Sidney Wolfe director of the Health Research Group at Public Citizen; editor of WorstPills.org
- Gardiner Harris science reporter for "The New York Times"
Most Recent Shows
Many doctors support Angelina Jolie's decision to have her ovaries removed two years after a preventive double mastectomy. We explore testing for BRCA genetic mutations and debate over surgery to reduce cancer risks.
For this month's Readers' Review: "All The Light We Cannot See" by Anthony Doerr. The 2014 novel weaves together the stories of a blind French girl and a German orphan during World War II.
Nearly 10,000 U.S. military personnel remain in Afghanistan after combat forces withdrew last year. We explore a meeting between U.S. and Afghan officials this week, prospects for Congressional approval of additional troops and the future of security in the region.